SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043101
Filing Date
2021-08-10
Accepted
2021-08-10 16:19:07
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20210630.htm   iXBRL 10-Q 3181320
2 EX-31.1 ubx-ex311_6.htm EX-31.1 21319
3 EX-31.2 ubx-ex312_7.htm EX-31.2 21237
4 EX-32.1 ubx-ex321_8.htm EX-32.1 14571
  Complete submission text file 0001564590-21-043101.txt   10305235

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ubx-20210630.xsd EX-101.SCH 64667
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20210630_cal.xml EX-101.CAL 54130
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20210630_def.xml EX-101.DEF 188479
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20210630_lab.xml EX-101.LAB 469553
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20210630_pre.xml EX-101.PRE 354453
10 EXTRACTED XBRL INSTANCE DOCUMENT ubx-10q_20210630_htm.xml XML 2026869
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 211160182
SIC: 2834 Pharmaceutical Preparations